CTCI Corp (9933)
Taiwan Stock Exchange · Taiwan · prices in TWD · close of 22 Oct 2026
Key indicators
| Last close | TWD 44.65 |
|---|---|
| 52-week range | 29.25 – 48.75 |
| Return, 1 month / 3 months | +9.2% / +11.2% |
| Return, 1 year / 3 years | +41.5% / +13.0% |
| Trend | Uptrend |
| RSI (14) | 61 |
| Volatility (1 year) | 35.3% |
| Worst drawdown (1 year) | -19.4% |
| Average daily value traded | 155.54M TWD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
CTCI Corp is an engineering, procurement and construction company based in Taiwan. It designs and builds industrial facilities, including petrochemical plants, power plants, and infrastructure projects, and it also provides related engineering services. Its customers are mainly energy, chemical, and public-sector organisations that need large plants and systems built and maintained. The company works on projects in Taiwan and in other markets, handling work from planning and design through construction and commissioning.
The shares are listed on the Taiwan Stock Exchange in Taiwan under the code 9933, and the price on this page is in New Taiwan dollars (TWD). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
CTCI Corp (9933) trades on the Taiwan Stock Exchange in Taiwan. It last closed at TWD 44.65 on 22 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 59 of 1,101 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 41.5% and over the last three months it rose 11.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Taiwan Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 86 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 18.3% | ||
| From 52-week high | -3.7% | ||
| Momentum | 79 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 11.2% | ||
| 6-month return | 20.7% | ||
| 12-month return, skipping the last month | 29.6% | ||
| Stability (higher is calmer) | 66 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.4% | ||
| Liquidity | 71 · Strong | Trades actively. | |
| Average daily value traded | 155.54M TWD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +5.3% |
|---|---|
| 1 month | +9.2% |
| 3 months | +11.2% |
| 6 months | +20.7% |
| 1 year | +41.5% |
| 3 years | +13.0% |
| 5 years | +35.4% |
Signals
| 50-day / 200-day average | 41.83 / 37.75 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.38 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jul 2023 | TWD 1.8960 |
| 1 Jul 2022 | TWD 2.2603 |
| 20 Aug 2021 | TWD 0.8660 |
| 24 Jul 2020 | TWD 1.2398 |
| 25 Jul 2019 | TWD 2.2549 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Taiwan Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.